References
- Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Resp Crit Care Med 2000; 161: 1781–5.
- Lane P, Gross SS. Nitric oxide: promiscuous and duplicitous. Sci Med 2002; 8: 96–107.
- Brouwer M, Chamolitrat W, Ferruzig G et al. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996; 88: 1857–64.
- Finke RG. Coenzyme B12-based chemical precedent for Co-C bond homolysis and other key elementary steps. In: Krau¨ tler B, Arigoni D, Golding BT (eds) Vitamin B12 and B12 Proteins. La Jolla, 1998, 383–402.
- Fenton WA, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Stanbury et al. (eds) Metabolic Basis of Inherited Disease. New York, 1989, 3129–49.
- Forsyth JC, Mueller PD, Becker CE et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. Clin Toxicol 1993; 31: 277–94.
- Bodian M. Neuroblastoma. Pediatr Clin North Am 1959; 6: 449–72.
- Matthews DM, Linnell JC. Vitamin B12: an area of darkness. BMA 1979; 2: 533–5.